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New Haven, ConnecticutABSTRACT Parkinson’s disease is characterized by the presence of intracellular aggregates composed primarily of the
neuronal protein a-synuclein (aS). Interactions between aS and various cellular membranes are thought to be important to
its native function as well as relevant to its role in disease. We use fluorescence correlation spectroscopy to investigate binding
of aS to lipid vesicles as a function of the lipid composition and membrane curvature. We determine how these parameters affect
the molar partition coefficient of aS, providing a quantitative measure of the binding energy, and calculate the number of lipids
required to bind a single protein. Specific anionic lipids have a large effect on the free energy of binding. Lipid chain saturation
influences the binding interaction to a lesser extent, with larger partition coefficients measured for gel-phase vesicles than for
fluid-phase vesicles, even in the absence of anionic lipid components. Although we observe variability in the binding of the
mutant proteins, differences in the free energies of partitioning are less dramatic than with varied lipid compositions. Vesicle
curvature has a strong effect on the binding affinity, with a >15-fold increase in affinity for small unilamellar vesicles over large
unilamellar vesicles, suggesting that aS may be a curvature-sensing protein. Our findings provide insight into how physical
properties of the membrane may modulate interactions of aS with cellular membranes.INTRODUCTIONa-Synuclein (aS) is a small, normally highly soluble
neuronal protein whose aggregation and deposition as
fibrillar amyloidogenic deposits is one of the hallmarks of
Parkinson’s disease (PD). Although its precise role in
disease progression is still unclear, three point mutations
to aS (A30P, E46K, and A53T) and gene multiplication
have been linked to early-onset PD (1–5), establishing that
it is critical to the pathology of the disease.
The sequence of aS is divided into three domains: a posi-
tively charged N-terminal region that contains repeats of the
highly conserved KTKEGV sequence, a central region
known as the non-amyloid-b component, and an acidic
C-terminal region (Fig. 1). Although intrinsically disordered
in solution, the N-terminal 100 residues form an amphi-
pathic a-helix upon membrane binding, whereas the
C-terminal region remains largely unstructured (6).
Natively, aS is localized to presynaptic terminals (7) and
there is evidence that it is involved in synaptic vesicle traf-
ficking and dopamine neurotransmission (8,9). In transgenic
mice, aS knockout is nonlethal, although studies of these
animals and in neuronal culture have reported altered dopa-
mine release and uptake (8,10), a decreased synaptic vesicle
pool (11), and changes in synaptic vesicle recycling (12).
PD pathology may be associated with a change or disruption
of native aS-lipid interactions, and in vitro studies indicate
that early-onset PD mutations modify aS lipid-binding and
aggregation propensities (13–16). It has also been suggested
that the mechanism of toxicity in PD involves direct, disrup-Submitted March 19, 2010, and accepted for publication July 26, 2010.
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Because of their potential relevance to both the native and
pathological roles of aS, characterization of the interactions
between aS and lipid membranes is of great interest.
Additional motivation for studying the interaction of aS
with various model membranes comes from the observation
that the physical properties of the membrane, such as alter-
ation of the lipid composition, may influence aS function or
dysfunction. For example, early studies found that aS has
a much greater affinity for highly curved vesicles (18–24),
and it was suggested that this preference may be related to
the proposed function of aS in binding to similarly highly
curved synaptic vesicles (20). Membrane curvature has the
ability to modulate the conformation of the helical region
of aS (25–29), providing a possible explanation for selective
binding to highly curved membranes. Furthermore, the
ability of aS to disrupt lipid bilayers or induce aggregation
in vitro, which has been suggested to be a mechanism for
aS-associated toxicity in PD (21,22,30–37), appears to be
dependent on lipid composition.
Although there exists a significant body of work aimed at
understanding the nature of interactions between aS and
lipid membranes, much of this work is qualitative and often
contradictory. Quantitative measurements of interaction
energies and factors contributing to membrane affinities
are largely lacking. For example, although there is a general
consensus that aS interacts preferentially with negatively
charged membranes, there is a lack of agreement as to
whether specific anionic lipids are required or preferred
(13,20–23,35,38–40). There are further conflicts as to
whether aS binds to membranes composed of zwitterionic
lipids, with varied reports of strong, weak, or no bindingdoi: 10.1016/j.bpj.2010.07.056
FIGURE 1 Schematic of aS illustrating three major regions. Shown are
the three PD-associated mutations (A30P, E46K, and A53T) and the site
of the cysteine mutation used for labeling (E130C).
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gested that binding requires highly curved vesicles
(19,20,23,24), more recent studies have shown binding to
model membranes of a variety of curvatures (18,21,22,
34,36,38–41), including planar supported bilayers (42,43).
In this work, fluorescence correlation spectroscopy (FCS)
is used to measure the interactions between aS and lipid
vesicles. We extract partition coefficients for aS using vesi-
cles of varying lipid compositions and sizes. We find that
specific anionic lipids have a dramatic effect on the binding
affinity, and aS binds with higher affinity to gel-phase
vesicles than to fluid-phase vesicles. In contrast, there are
relatively minor differences in the free energies of partition-
ing between the wild-type (WT) and disease-associated
mutants. Binding exhibits a nonlinear dependence on curva-
ture, resulting in a moderate range of partitioning free
energies. The number of lipids in the binding site of a single
aS is independent of curvature and composition, and corre-
sponds well to the estimated size of the membrane-bound
a-helical region of aS. For context, we compare our mea-
sured partition coefficients to published values for aS.MATERIALS AND METHODS
The value aS was expressed, purified, and fluorescently labeled as
described previously (25) (see Supporting Material).Vesicle preparation
The lipids usedwere 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphate (POPA), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (POPG), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), and 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG)
(Avanti Polar Lipids, Alabaster, AL). Lipids were dissolved to 10–
20mg/mL in chloroform and stored at20C.Aliquots were removed, dried
with nitrogen, and dehydrated in a vacuum-evacuated desiccator overnight.
The resulting lipid film was rehydrated in MOPS buffer (20 mM MOPS,
147 mMNaCl, 2.7 mM KCl, pH 7.4) for 1 h. For preparation of large unila-
mellar vesicles (LUVs), aqueous lipid solutions were extruded 21 times
through two stacked membranes (Whatman Nucleopore Track-Etch,
Maidstone, UK) with 30 nm, 50 nm, 100 nm, or 200 nm diameter pores in
a Liposofast extruder (Avestin, Ottawa, Canada). Lipid solutions containing
DPPCorDPPGwere heated to 55C (above themelting temperatures) before
extrusion. For preparation of small unilamellar vesicles (SUVs), rehydrated
lipids were sonicated for 30min on ice using a flat tip on aMisonix sonicator
3000 at 50% duty (Farmingdale, NY). SUVs were centrifuged at 8000 g for
15 min to remove particulate matter. All vesicles were assayed for inorganic
phosphate to determine the total lipid concentration (44,45) and character-
ized by dynamic light scattering (DLS; see Supporting Material). All lipidBiophysical Journal 99(7) 2279–2288compositions are given as molar ratios of components, and all protein/lipid
ratios are given as molar ratios of protein to accessible lipid (see Supporting
Material for calculation of accessible lipid).Fluorescence correlation spectroscopy
FCS measurements were made on an instrument bulit in house based on an
inverted Olympus IX-71 microscope as described previously (46). The vesi-
cles were smaller than the dimensions of the focused laser beam, and both
vesicles and protein freely diffused within the focal volume. Measurements
were made in eight-well chambered coverglasses (Nunc, Rochester, NY)
that were first treated to prevent aS from adsorbing to the chamber surfaces
(Supporting Material).
Binding studies were made using a constant concentration of aS and
varying the lipid concentrations. The samples were allowed to equilibrate
for 5 min after mixing before measurement, and all measurements were
at 20.55 0.1C in MOPS buffer. A complementary binding curve was ob-
tained by adding increasing amounts of aS to vesicles in pH 5.0 MOPS
buffer until the lipid/bound protein ratio reached a saturating value. All
data shown are from at least two separate binding curves under identical
conditions. For all studies, each autocorrelation curve was 10 s, repeated
25–30 times. Increasing the measurement time to 30 s for larger vesicles
(47) did not results in any change in the autocorrelation curves. The curves
were averaged together to obtain statistical variations used for weighting in
the fitting outlined below. Fitting was done with the use of MATLAB (The
MathWorks, Natick, MA).
The average curve was fit to Eq. 1 for multiple species of differing bright-
ness diffusing in a three-dimensional Gaussian volume (48,49):
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The only free parameters in Eq. 1 are N, the number of proteins, FF, the
fraction of aS free in solution, and Q, the average brightness of the vesicles
relative to a single aS (Supporting Material). The fraction of aS bound to
vesicles, FB, is 1  FF. The structure factor s, the ratio of the radial to axial
dimensions of the focal volume, was determined as a free parameter for
solutions of Alexa488 hydrazide dye and then fixed to the experimentally
determined value of 0.2 for all subsequent fitting. The diffusion times taS
and tvesicle (for aS and vesicles, respectively) were measured independently
and fixed for binding measurements. The vesicles were not completely
homogeneously sized, but were distributed around the average value
measured by FCS and DLS. Simulations by our group and others (50) illus-
trate that the diffusion time returned is a population-weighted average, and
that a single tvesicle is an accurate representation of the average properties of
the true distribution (Supporting Material for fit equation and details).Partition coefficient and DG calculations
FB extracted from fitting the autocorrelation curve was plotted as a function
of accessible lipid to obtain binding curves. The curves were fit by means of
a hyperbolic equation using Origin (OriginLab, Northampton, MA):
FB ¼ x
Kd;app þ x (2)
where FB is the fraction aS bound from fitting to Eq. 1, x is the concentra-
tion of accessible lipids (see Supporting Material for calculation), and
Kd,app (the apparent dissociation constant) is the midpoint of the binding
curve.
FIGURE 2 Binding of aS to vesicles. (A) Normalized autocorrelation
curves show a shift to longer times as aS binds to vesicles (from left to right
with increasing lipid concentration). (B) aS binding curve derived from
FCS measurements using Eq. 1 in the text (squares) is fit well by a hyper-
bolic equation (Eq. 2 in the text; line).
Quantifying aS Binding to Vesicles 2281A molar partition coefficient (Kp) for each sample was calculated from
Kd,app using Kp ¼ [aSlipid]/[aSfree] (51), where [aSlipid] is the moles of
aS bound per volume of lipid, and [aSfree] is the moles of aS free per
volume of aqueous solution. [aSlipid] can be calculated from [aSbound],
a parameter calculated from the FB extracted from fitting FCS data, as
[aSlipid] ¼ [aSbound]  (total volume / lipid volume). Since Kd,app is the
concentration of lipid when [aSbound]¼ [aSfree], Kp is calculated according
to Kp ¼ [Kd,app  NA  vlipid]1, where vlipid is the volume of one lipid
molecule and NA is Avogadro’s number. Individual Kp values were aver-
aged and the error of the fit to a hyperbolic curve was propagated for uncer-
tainty in all calculations. DG of partitioning was calculated as RTlnKp.
RESULTS
Characterization of vesicles
During extrusion, vesicles can undergo fragmentation,
reforming vesicles with a diameter characteristic of the
bending modulus of the lipid and limiting the smallest
attainable diameter (52). In our experiments, an accurate
measurement of the vesicle size is important both for data
fitting and for achieving a meaningful understanding of
the role of curvature in binding. By DLS, vesicles composed
of 1:1 POPS/POPC extruded through membranes with
30 nm, 50 nm, 100 nm, and 200 nm pores were found to
have diameters of 775 11 nm, 935 17 nm, 1165 22 nm,
and 1825 11 nm, respectively, and thus can be described as
LUVs. SUVs exhibited the higher polydispersity character-
istic of sonicated vesicles and had an average diameter of
46 nm, making them a good model for ~40 nm synaptic
vesicles (53). The relationship between vesicle diffusion
times measured by FCS and the diameters determined by
DLS was linear (Fig. S2). We saw no evidence of protein
or vesicle aggregation, even at protein/lipid ratios much
higher than those used in our studies, by either FCS or
DLS (Supporting Material and Fig. S3).
The vesicles used in this study are simplified membranes
that allow us to measure the effects of certain parameters on
aS-membrane binding in the absence of other membrane-
associated proteins. Although they do not closely resemble
physiological membranes, many conditions were controlled
to mimic cellular membranes whenever possible. Palmitoyl/
oleoyl tails were chosen to mimic the tail asymmetry and
monounsaturation of physiological lipids, and the PC head-
group is the most common zwitterionic headgroup found
in vivo. Although the anionic content of the vesicles is
higher (50%) than that of synaptic vesicles (~30%), and
specific lipids such as PA are present only in very small
amounts in cellular membranes, our choice of compositions
allowed measurement of complete binding curves and a
closer comparison with previous qualitative and quantitative
studies that overwhelmingly used vesicles with a high
anionic content.
aS binds as a monomer
Binding curves were measured by FCS. As vesicles were
added to a constant concentration of aS, the autocorrelationcurve shifted to longer decay times reflecting binding of aS
to the vesicles (Fig. 2 A). At each lipid concentration, the
fraction of aS bound was found with the use of Eq. 1.
Binding curves were fit to Eq. 2 to obtain Kd,app, which
was then used to calculate thermodynamic parameters Kp
and DG of partitioning for comparison with other measure-
ments.
The hyperbolic shape of the binding curve (Fig. 2 B) is
consistent with a noncooperative binding model wherein
monomeric aS binds to identical binding sites on the lipid
bilayer. It also suggests that aS does not oligomerize upon
binding, which may manifest as a sigmoidal or otherwise
nonhyperbolic binding curve. Although sigmoidal binding
curves and clustering of aS bound to a membrane were
observed in previous studies (20,31,38,42,43), differences
between those studies and our own may be explained by
differences in experimental conditions, including the rela-
tive amounts of protein/lipid and the observation method
used. The low protein concentrations and short measure-
ment times employed for FCS are expected to reduce the
propensity of aS to aggregate. Of note, we observed a corre-
lation between low labeling efficiency of aS and theBiophysical Journal 99(7) 2279–2288
2282 Middleton and Rhoadesappearance of sigmoidal binding curves (data not shown),
which were reported in an earlier FCS study of aS binding
(38). The hyperbolic shape of the curve can be recovered by
including a reducing agent during measurements (data not
shown). This finding suggests that unlabeled aS has an
altered interaction with the bilayer when it has a free
cysteine, possibly as a result of forming covalent dimers,
which have been reported to bind lipid bilayers with higher
affinity than monomer aS and increase cellular toxicity
(14,33,54).Anionic headgroups and chain saturation
Using 93 nm vesicles composed of anionic lipids POPS,
POPG, or POPA in 1:1 mixtures with zwitterionic POPC,
we measured the binding affinity of WT aS. Although there
are mixed reports for many individual lipids, the trend sug-
gested by our data, PA>PSzPG (Fig. 3 A), is in agreementFIGURE 3 Molar partition coefficients (Kp) of aS. Comparison of Kp
values measured for (A) WT aS with 93 nm LUVs of six different lipid
compositions, (B) WT with 1:1 POPS/POPC vesicles covering a range of
diameters, and (C) WT and disease-associated aS mutants with 93 nm
1:1 POPS/POPC vesicles.
Biophysical Journal 99(7) 2279–2288with and unifies many of the qualitative observations of
various lipids that have been reported (13,21–23,29,
36,38). Whereas aS binds to POPG and POPS with similar
affinities, it binds to POPA with >60 times greater affinity
(Fig. 3 A and Table 1). In comparison with an earlier FCS
study that found a Kd,app of ~50 mM for WT binding 1:1
POPS/POPC LUVs with ~120 nm diameter (38), our Kd,app
of 169 mM for 116 nm LUVs is somewhat higher, reflecting
both the higher salt concentration used in our work and
differences in the equations used to fit the FCS binding
curves. The equation used in this work takes into account
the brightness of vesicles with aS bound, which tends to
result in a higher calculated Kd,app (Fig. S1).
Many previous studies of the effects of various anionic
lipidsonaSbinding indicated that thepresenceof a negatively
charged lipid is required for binding of aS (13,21–23,40,41),
and thus the very low affinity of aS for POPC was unsur-
prising (Fig. 3A andTable 1).However, the free energy of par-
titioning for POPC is still a significant 3.89 kcal/mol,
suggesting that electrostatic interactions are not the only
important factor for binding. To further explore the role of
other bilayer properties, we made 93 nm vesicles composed
of 1:1 DPPG/DPPC. The lipid tails of POPG and POPC areTABLE 1 Apparent dissociation constants (Kd,app), molar
partition coefficients (Kp), and free energies of partitioning
(DG) for WT and mutant aS with various LUVs
Kd,app (mM) Kp DG (kcal/mol)
(A) Lipids
POPA/POPC 1.605 0.49 825,0005 254,000 7.945 0.18
POPS/POPC 100 5 5 13,2005 630 5.535 0.03
POPG/POPC 128 5 11 10,3505 890 5.395 0.05
POPC 16905 210 7855 99 3.895 0.07
DPPG/DPPC 48 5 12 31,1005 8200 6.035 0.15
DPPC 2415 137 6,0005 3400 5.075 0.33
(B) Diameter (nm)
46 5.7 5 1.3 234,0005 53,000 7.215 0.13
77 75 5 14 17,5005 3300 5.705 0.11
93 1005 5 13,2005 630 5.535 0.03
116 1695 6 7,8005 280 5.235 0.02
162 136539 9,7005 2800 5.355 0.17
46 (DPPC)* 46 5 10 31,0005 7000 6.045 0.12
(C) Mutants
93 nm vesicles
WT 1005 5 13,2005 630 5.535 0.03
A30P 2825 12 4,6905 190 4.935 0.02
A53T 1025 9 12,9005 1100 5.525 0.05
E46K 46.65 4.6 28,4005 2800 5.985 0.06
46 nm vesicles
WT 5.7 5 1.3 234,0005 53,000 7.215 0.13
A30P 8.9 5 2.2 149,0005 36,000 6.955 0.14
A53T 7.0 5 1.1 189,0005 31,000 7.095 0.10
E46K 1.6 5 0.4 804,0005 207,000 7.935 0.15
(A) WT aS and 93 nm diameter vesicles with varying anionic headgroups or
chain saturation. (B) WT aS and 1:1 POPS/POPC (*or DPPC) vesicles of
different curvatures. (C) aS mutants and 1:1 POPS/POPC vesicles of either
93 nm or 46 nm diameter. Kp and DG of partitioning were calculated as
described in the text.
Quantifying aS Binding to Vesicles 2283asymmetric in length and contain one unsaturated chain; in
contrast, DPPG and DPPC tails are symmetric and saturated.
Furthermore,whereas POPGandPOPC formdisordered fluid
phases at room temperature, DPPG and DPPC form gel
phases (55). We measured the binding of aS to DPPG/
DPPC vesicles and found that Kp was increased threefold as
compared to fluid-phase POPG/POPC (Fig. 3 A and Table 1).
A larger effectwas seenwith the zwitterionic lipids, wherewe
observed an almost 10-fold enhancement in Kp of aS for
DPPC relative to POPC (Fig. 3 A and Table 1). Our findings
are in contrast to previous work that suggested that aS bound
zwitterionic gel-phase SUVs but not LUVs or giant unilamel-
lar vesicles (GUVs) (18–20,41). Moreover, the Kp for DPPC
vesicles is only approximately a factor of 2 less than that for
disordered fluid-phase vesicles containing 50%anionic PG or
PS (Table 1), suggesting a specific, strong interaction with
these lipids.FIGURE 4 Determination of the number of lipids in a binding site. aS
was added to 93 nm (squares) or 46 nm (circles) 1:1 POPS/POPC vesicles
at pH 5. The curve saturates at an accessible lipid/bound protein molar ratio
of ~20:1 (dashed line).Curvature and PD mutants
We studied the effect of vesicle diameter on aS binding
using POPS/POPC vesicles ranging from 46 nm to 182 nm
in diameter (Fig. 3 B and Table 1). We found that aS binds
more strongly to vesicles with a smaller diameter, in agree-
ment with some previous reports (19,23,35,39), but that
highly curved SUVs are not required for binding either
anionic or zwitterionic membranes. The difference in
binding 77–182 nm vesicles is moderate and the Kp values
change by just over a factor of 2 for these vesicles, corre-
sponding to a difference in DG of <0.5 kcal/mol. However,
there is a strong increase in binding 46 nm vesicles: for 1:1
POPS/POPC vesicles, Kp is >10 times greater for 46 nm
vesicles compared to 77 nm. A similarly dramatic increase
in affinity was observed for SUVs made of 100% DPPC
(~5 times greater; Table 1), as well as 100% POPS and
100% POPC (data not shown).
The effect of aS pathological mutants on interactions
between aS and lipid membranes is of interest because it
has been suggested that perturbation of normal membrane
interactions may be important for the role aS plays in
PD (56). Given our observation that WT aS binds with
a significantly higher affinity to SUVs, which are similar
in size to synaptic vesicles, we measured the affinity of
WT aS and the PD mutants for both 93 nm LUVs and
46 nm SUVs composed of 1:1 POPS/POPC. For both sizes
of vesicles, we find that the relative binding strengths of
these mutants are E46K>WT¼A53T>A30P (Fig. 3 C and
Table 1), in support of the previously observed trend
(13,20,22,41,57,58). The DG of partitioning ranges from
4.93 to 5.98 kcal/mol for 93 nm vesicles, and from
6.95 to 7.93 kcal/mol for 46 nm vesicles. However,
these DG calculations show that there is only an ~1 kcal/
mol difference in free energies between the strongest
(E46K) and weakest (A30P) interactions for both LUVs
and SUVs.To determine whether the large difference in binding
affinity between LUVs and SUVs could be explained by
an increase in the amount of aS bound per vesicle, we per-
formed experiments under saturating conditions. In contrast
to our previous measurements, for which we added vesicles
to a fixed concentration of protein, we used a fixed concen-
tration of lipid and varied the amount of protein until the
amount of bound protein reached saturation. A plot of the
molar ratio of lipids to bound aS as a function of total aS
concentration plateaus at a value that corresponds to the
number of lipids in the binding site (Fig. 4). These experi-
ments were carried out at pH 5.0 where stronger binding
allowed for a more accurate calculation of saturation, using
vesicles composed of 1:1 POPS/POPC. The plateau value
was ~20 lipids in the outer leaflet per aS for 93 nm and
46 nm vesicles (~40 in the bilayer), an estimate of the
number of lipids in an aS binding site. These experiments
were repeated using 93 nm 100% POPS vesicles with the
same results (data not shown).DISCUSSION
Strength of binding interaction
A rigorous treatment of membrane partitioning includes
corrections for electrostatic effects that depend on the
charge of the protein, the charge density of the membrane,
and the buffer conditions (59,60). We chose not to correct
for these factors because the presence of specific anionic
lipids may contribute to in vivo membrane affinities. There-
fore, the Kp-values reported here are not due to purely
hydrophobic partitioning; rather, they reflect both hydro-
phobic and electrostatic contributions. Although exact
comparisons with other published thermodynamic parame-
ters for aS-membrane binding are not possible due to differ-
ences in experimental conditions (e.g., vesicle compositions
and diameters, temperatures, and buffers), we will considerBiophysical Journal 99(7) 2279–2288
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values as closely as possible. For simplicity, we have calcu-
lated the affinity coefficients as defined in each study from
our measurements.
Sto¨ckl et al. (41) reported a Ka,app-value of ~2 mM
1 for
aS binding 1:1 DOPG/DOPC GUVs, which is significantly
lower than our Ka,app of ~8 mM
1 for 1:1 POPG/POPC
93 nm LUVs. Although our data suggest that increasing
vesicle diameter will have a minimal effect on Ka.app for
vesicles larger than ~77 nm diameter, the higher affinity
we measure may be due to our use of LUVs instead of
GUVs, or our use of an assay that does not rely on a
secondary change in fluorescence to detect binding. Kamp
and Beyer (19) and Nuscher et al. (20) used fluorescence
anisotropy and isothermal titration calorimetry to measure
DG values ranging from 10.1 to 10.7 kcal/mol for
DPPC and POPG/POPC SUVs < 40 nm in diameter. We
calculate DG ¼ 7.05 kcal/mol and DG ¼ 6.04 kcal/mol
for 46 nm 1:1 POPS/POPC and DPPC vesicles, respectively,
which should correspond closely to their results. Given the
dramatic increase in affinity that we measure between
77 nm and 46 nm vesicles, it is possible that the remaining
~3–4 kcal/mol discrepancy may be due to the slight differ-
ence in SUV diameters used. However, it is also possible
that other experimental factors played a role, as the authors
did not observe binding to DPPC or POPG/POPC LUVs, in
contrast to our observations.
Another fluorescence study found Kd,app-values of
1.556 mM and 1.863 mM for WT and A53T binding
POPS LUVs, respectively, and 1.645 mM for WT binding
~100 nm POPC LUVs (39). These values are lower than
the Kd,app-values we measure for ~93 nm LUVs: 100 mM
and 102 mM for WT and A53T binding 1:1 POPS/POPC,
respectively, and 1.7 mM for WT binding POPC. The
POPS results can be partially explained by the molar
fraction of POPSused, since ourKd valueswould be expected
to be ~10-fold larger than for 100% POPS LUVs. There is
qualitative agreement between our results and those of Nar-
ayanan and Scarlata (39), both of which reveal similar
binding affinities for WT and A53T. However, they found
little difference between binding to POPC as compared to
POPS vesicles, in conflict with our observations.
Also of interest are other amphipathic membrane-binding
proteins, as exemplified by a recent study of a helix from an
N-BAR domain, which plays a role in membrane remodeling
in endocytosis (61).Kp-values of N-BAR range from 2 104
to 5.5  104 for POPG and POPS LUVs extruded through
30 nm, 100 nm, and 400 nm pores (61), and these values
are in very good agreement with our measured values for
aS under similar conditions (Table 1). Both aS and N-BAR
showaKp orders ofmagnitudeweaker for POPC than anionic
lipids, suggesting that anionic lipidsmediate binding for both
proteins. In light of a recent study showing that aS is capable
of tubulating and otherwise rearranging lipid bilayers (30)
and long-standing observations that aS can disrupt lipidBiophysical Journal 99(7) 2279–2288bilayers (21,22,30–37), the comparable affinities of the two
proteins suggest that aS may have a similar functional role
in rearranging or maintaining bilayer structures.
For the PDmutants, our quantitative results can be used to
provide insight into the source of altered binding in the A30P
and E46K mutations. The E46K mutation exchanges a
residue with 1 charge for one with þ1 charge, causing a
net charge difference of þ2. This is expected to enhance
the affinity of aS for negatively charged membranes due to
electrostatic attraction. Model polylysine peptides have
been used to calculate that partitioning of one lysine residue
into a negatively chargedmembrane under conditions similar
to ours should result in ~1 kcal/mol enhancement in binding
(62). Because this lysine replaces a negatively charged gluta-
mic acid, we might expect twice that effect, or ~2 kcal/mol.
For comparison, when DGassociation is calculated from the
apparent association constant, Ka,app, the difference between
WT and E46K is 0.45 kcal/mol for 93 nm vesicles and
0.72 kcal/mol for 46 nm vesicles, much less than expected.
To understand this discrepancy, we considered a helical
wheel model of the N-terminal a-helix of aS, which suggests
that E46 is on the solvent-exposed face of the helix (63). Thus
the interaction of E46K with negatively charged lipid head-
groups is likely to be limited, and increased binding is not
due to lysine partitioning into themembrane. The added posi-
tive charge may play a role in attracting aS to the membrane
from bulk solution, thus increasing the concentration of aS
near the membrane and the measured Kp.
The A30P mutation inserts a proline into the region of the
protein that is a-helical when bound to the lipid bilayer.
Proline is known to introduce a kink into helices, which has
been suggested as the reason for reduced A30P binding. An
additional possibility concerns the A30 position as a lipid-
exposed residue (27,28,63). Alanine is a more hydrophobic
residue than proline, and inserting proline in place of alanine
in the lipid interface is likely to reduce beneficial hydro-
phobic interactions (64,65). The affinity ofA30P is ~30 times
greater for the 46 nm SUVs than for 93 nM LUVs, as
compared to WT, where the affinity is ~18 times greater
(Table 1). Thus the relative difference in binding affinities
is much smaller between A30P and WT for SUVs than
LUVs, suggesting that the mechanism of disruption is less
important for highly curved bilayers, such as the synaptic
vesicles relevant to the native function of aS. The relatively
minor differences in the binding affinities of WT, A30P,
and A53T suggest that a perturbation of functional binding
interactions is not necessarily a mechanistic link to disease.Effects of composition
One finding of significant interest from our studies is that Kp
of aS is>60-fold greater for PA than for PS or PG (Table 1).
The higher charge on the PA headgroup at pH 7.4 (1.2)
compared to PS and PG (1) offers a partial explanation.
We expect both hydrophobic and electrostatic effects to
Quantifying aS Binding to Vesicles 2285contribute to the free energy of binding (as indicated by
binding to zwitterionic POPC; Table 1), and if we reason-
ably assume that the hydrophobic contributions should be
similar for all lipid compositions compared, we can expect
log(Kp) to scale linearly with the charge density of the
membrane (66,67). The Kp derived from our data is much
higher than this, suggesting that other properties of PA
must play a role in aS binding. It has been suggested that
the smaller PA headgroup results in additional space for a
protein to bind without rearranging lipids in the membrane,
which is consistent with our results (38). Single-molecule
fluorescence resonance energy transfer measurements of
aS bound to POPA and POPS vesicles show similar struc-
tures, indicating that there is no significant structural differ-
ence (data not shown) (25). Binding affinity also does not
scale with the chain packing density (PA>PS>PG) (68),
in agreement with models showing that aS interacts mainly
with lipid headgroups (69).
The affinity of aS for specific anionic lipids can be exam-
ined with respect to their physiological concentrations. It
has been shown in aging mice that amounts of PA in the
brain increase while PG, PS, and PC decrease (70). In mouse
models transgenic for aS, the amount of PA decreases, PG
and PS increase, and PC is unaffected, implying that the
presence of aS alters lipid metabolism. Since we have
shown that aS can bind PA much more tightly than PS
and PG, it is possible that membrane interactions of aS
play a role in this process (71–74). Depending on the exact
relative amounts of PA, PS, and PG in the relevant mem-
brane and changes in these amounts due to aging, the effect
of aging on lipid composition could significantly enhance or
decrease aS binding.Curvature and binding density
The number of lipids in the aS binding site gives insight
into the geometry of the interaction, and reports of this
number in the literature are varied. Values range from 3 to
377 lipids in the bilayer, although these numbers should
be taken as an upper limit because they were not necessarily
measured under saturating conditions (18,19,21,30). Mea-
surements taken under saturating conditions have yielded
values of at least 36 lipids from electron spin resonance
(40), fewer than three lipids by nuclear magnetic resonance
(30), and 85 lipids by FCS (38). Our results suggest that
20 surface-accessible lipids make up a binding site, corre-
sponding to ~40 total lipids, in excellent agreement with
ESR measurements (40). The theoretical minimum number
of accessible lipids needed to bind aS as an extended helix
has been estimated to be 12–30 (30,38,40), and our mea-
sured value falls in the middle of this range. Although
these calculations vary considerably with the area per lipid
headgroup and number of helix-forming residues used, our
measurements are likely consistent with aS forming rela-
tively tightly packed, extended helices.Because we measure the same number of lipids in a
binding site for 93 nm vesicles composed of POPS or 1:1
POPS/POPC as well as for 46 nm 1:1 POPS/POPC vesicles
(Fig. 4), it is likely that the membrane surface area—not the
lipid charge or number of defects—limits the density of aS
at saturation. This is in contrast to a recent study that exam-
ined binding of the amphipathic helix from endophilin A1
(75) using a novel fluorescence method that allows the
size of individual vesicles within a heterogeneously sized
population to be characterized. The authors found that the
binding affinity changed by a factor of ~2 for vesicles span-
ning a range from 50 nm to 200 nm, whereas the density of
protein bound was dramatically higher for smaller vesicles.
They concluded that the increase in binding was due to an
increased density of defects in the more highly curved
surfaces rather than an increased affinity for the curved
surfaces themselves.
Our own results suggest the opposite conclusion for aS,
namely, that it has an increased affinity for highly curved
bilayers, with the attraction for binding at sites of defects
playing a more minor role. This idea is supported by our
observations of a moderate increase in binding affinity for
gel-phase vesicles over disordered fluid-phase vesicles as
compared to the dramatic increase observed for SUVs
over LUVs composed of 1:1 POPS/POPC and DPPC
(Table 1), as well as POPS and POPC. Gel-phase mem-
branes contain more defects compared to fluid-phase mem-
branes, and this has specifically been shown for DPPC as
compared to POPC (76–78). The smaller difference
between DPPG/DPPC and POPG/POPC is likely due to
the strength of the electrostatic interaction, which dominates
when anionic lipids are present. Nonelectrostatic contribu-
tions to binding must dominate the interaction of aS with
zwitterionic lipids, and may increase the stability of aS in-
teracting with membranes with a significant proportion of
zwitterionic lipids, such as those found in vivo.
The mean curvature of the lipid bilayer, 1/R, changes by
a factor of ~4 between the 182 nm and 46 nm vesicles. In
similarity to our observations for aS, a sharp binding affinity
transition at these curvatures has been observed for proteins
containing amphipathic lipid-packing sensor motifs, which
have been suggested to be important for controlling or
sensing membrane curvature (79). The native function of
aS likely involves interactions with synaptic vesicles, and
our findings in a model system suggest that the curvature
of the membrane may drive this interaction, perhaps by
closely matching the ideal curvature of the N-terminal helix.
Twisting of the helix is necessary to attain the observed 11/3
periodicity (80), which may provide the necessary ideal
curvature for binding SUVs or synaptic vesicles (27).CONCLUSIONS
Although the physiological relevance of interactions of aS
with lipid membranes is widely recognized, many of theBiophysical Journal 99(7) 2279–2288
2286 Middleton and Rhoadesfactors that affect these interactions are poorly understood.
Our results provide quantitative measurements of the contri-
butions from disease-associated protein mutations, as well
as the effects of membrane curvature, lipid headgroup,
and lipid phase state. They suggest a model in which strong
binding is driven by electrostatic attraction between
the negatively charged bilayer and positively charged
N-terminus of aS, and an intrinsic affinity for highly curved
lipid surfaces, which may be modulated by specific lipid
components and the presence of bilayer defects. These find-
ings demonstrate that aS may interact with a variety of
cellular membranes in vivo and provide insight into the
role of aS in disease.SUPPORTING MATERIAL
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